Understanding acute invasive fungal rhinosinusitis for better treatment outcomes


  • Monika Patel Department of ENT and HNS, BVDUMC, Pune, Maharashtra, India
  • Maitri Kaushik Department of ENT and HNS, BVDUMC, Pune, Maharashtra, India
  • Arun Dehadaray Department of ENT and HNS, BVDUMC, Pune, Maharashtra, India
  • Gargi Kar Department of ENT and HNS, BVDUMC, Pune, Maharashtra, India




Hypocalcemia, Parathyroid, Recurrent laryngeal nerve, Thyroidectomy


Background: Objectives of the study were to identify factors that affect patient survival, determine treatment outcomes in various clinical presentations, increase awareness amongst clinicians and provide more accurate treatment options to patients. Study design was a retrospective study. Study places were Tertiary care centre and a Medical College.

Methods: A series of patients diagnosed and treated for acute invasive fungal rhinosinusitis over a period of 7 years.  

Results: Twelve patients were reviewed out of which eleven were diabetic. Most common fungus encountered was mucor. Six cases presented as sinonasal disease, four as rhino-orbital disease and two as rhino-orbito-cerebral disease. All the patients underwent surgical debridement with systemic antifungal treatment. It was seen that diseases confined to sino nasal areas had good prognosis. Early diagnosis and prompt intervention is major factor for better prognosis.

Conclusions: Immunocompromised patients in ICU with ocular symptoms should be meticulously screened for invasive fungal rhinosinusitis. Early diagnosis and prompt management with surgical debridement and systemic antifungal treatment is utmost important factor in good prognosis. Intensivists and also the physicians should be made cognizant as they play important role in patient management as well. Multidisciplinary approach is the need of hour.


Karthikeyan P, Coumare VN. Indian J Otolaryngol Head Neck Surg. 2010;62(4): 381-5.

Chopra H, Kapil D, Neha C, Sanjeev P, Vikrant M. Invasive fungal rhinosinusitis: our experience. Clin Rhinol. 2009;2:21-5.

Chakrabarti A1, Denning DW, Ferguson BJ, Ponikau J, Buzina W, Kita H, Marple B, et al. Fungal rhinosinusitis: A categorization and definitional schema addressing current controversies. Laryngoscope. 2009;119:1809-18.

Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47:503-9.

Turner JH, Sondry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal rhinosinusitis: A systematic review and quantitative synthesis of published evidence. The Laryngoscope. 2013;123(5):1112-8.

Blitzer A, Lawson W, Meyer BR, Biller JF. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope. 1980;90:635-48.

Ochi JW, Haris JP, Feldman JI. Rhinocerebral mucormycosis: results of aggressive surgical debridement and Amphotericin B. Laryngoscope. 1988;98:1339.






Original Research Articles